One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-145124
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 2 |
Affiliation: University of Washington Medical Center, The University of Texas MD Anderson Cancer Center, Takeda (United States), Millennium Engineering and Integration (United States), Washington University in St. Louis, Memorial Sloan Kettering Cancer Center, Universitätsmedizin Göttingen, University of Manchester, Institut Català d'Oncologia, Stanford Blood Center, Harvard University, Seagen (United States), University of British Columbia, Northwestern UniversityThe Echelon-2 Trial: 5-Year Exploratory Subgroup Analyses of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Vs CHOP in Frontline Treatment of Pts with CD30-Positive Peripheral T-Cell Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
